Headlines
- Solvent Effects on Blood Coagulation
- Abel, et al. Chem Med Chem, 2011
- WaterMap Interrogation of PCSK9
- Pearlstein, et al. Proteins, 2010
Welcome to Nimbus Discovery
Nimbus Discovery is using breakthrough computational chemistry to identify drug candidates against previously inaccessible biological targets. In doing so, Nimbus seeks to unlock fundamental disease pathways with new and differentiated medicines. Nimbus has established a first-of-its-kind partnership with Schrödinger, the leader in computational drug discovery, to gain privileged access to cutting-edge technology and exclusive rights to key targets. In the first year, the partnership has already delivered selective, potent, and differentiated compounds for IRAK4 and ACC, two targets pivotal in the progression of diffuse B-cell lymphoma and metabolic disease respectively.